<?xml version="1.0" encoding="UTF-8"?>
<ref id="B81">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Milne</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Thomsen</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mølgaard Knudsen</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Rubaszka</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kristensen</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Borodina</surname>
    <given-names>I.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives.</article-title>
  <source>
   <italic>Metab. Eng.</italic>
  </source>
  <volume>60</volume>
  <fpage>25</fpage>–
  <lpage>36</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.ymben.2019.12.007</pub-id>
  <?supplied-pmid 32224264?>
  <pub-id pub-id-type="pmid">32224264</pub-id>
 </mixed-citation>
</ref>
